Clinical Trials Logo

Angelman Syndrome clinical trials

View clinical trials related to Angelman Syndrome.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT03882918 Terminated - Angelman Syndrome Clinical Trials

An Open-Label Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of OV101 in Individuals With Angelman Syndrome

ELARA
Start date: January 31, 2019
Phase: Phase 3
Study type: Interventional

This open-label study (OV101-18-002) will evaluate the long-term (52 weeks) safety of OV101 in subjects with AS and provide additional OV101 treatment to those subjects who completed Study OV101-15-001 (NCT02996305). Subjects with AS who completed the pharmacokinetic Study OV101-16-001 (NCT03109756) will also be permitted to participate, provided they meet all entry criteria.